Open access · CC-BY
via OpenAlex
Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly
Branca Isabel Pereira, Xiao‐Ning Xu, Arne N. Akbar
Frontiers in Immunology · 2020 · ▲ 198 citations
Abstract
One of the most appreciated consequences of immunosenescence is an impaired response to vaccines with advanced age. While most studies report impaired antibody responses in older adults as a correlate of vaccine efficacy, it is now widely appreciated that this may fail to identify important changes occurring in the immune system with age that may affect vaccine efficacy. The impact of immunosenescence on vaccination goes beyond the defects on antibody responses as T cell-mediated responses are reshaped during aging and certainly affect vaccination. Likewise, age-related changes in the innate immune system may have important consequences on antigen presentation and priming of adaptive immune responses. Importantly, a low-level chronic inflammatory status known as inflammaging(definition) has been shown to inhibit immune responses to vaccination and pharmacological strategies aiming at blocking baseline inflammation can be potentially used to boost vaccine responses. Yet current strategies aiming at improving immunogenicity in the elderly have mainly focused on the use of adjuvants to promote local inflammation. More research is needed to understand the role of inflammation in vaccine responses and to reconcile these seemingly paradoxical observations. Alternative approaches to improve vaccine responses in the elderly include the use of higher vaccine doses or alternative routes of vaccination showing only limited benefits. This review will explore novel targets and potential new strategies for enhancing vaccine responses in older adults, including the use of anti-inflammatory drugs and immunomodulators.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fimmu.2020.583019
- Canonical
- link ↗
- Fetched
- 2026-10-02 MST
Cite this
APA
Pereira, B.I., Xu, X., & Akbar, A.N. (2020). Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly. <em>Frontiers in Immunology</em>. https://doi.org/10.3389/fimmu.2020.583019
Vancouver
Pereira BI, Xu X, Akbar AN. Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly. Frontiers in Immunology. 2020. doi:10.3389/fimmu.2020.583019.
BibTeX
@article{branca2020Target,
title = {Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly},
author = {Branca Isabel Pereira and Xiao‐Ning Xu and Arne N. Akbar},
journal = {Frontiers in Immunology},
year = {2020},
doi = {10.3389/fimmu.2020.583019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Seminars in Immunopathology 2023
Open access · CC-BY
Differences in the post-stroke innate immune response between young and old
Vanderbilt University Medical Center 2019
Open access · US-GOV
Single Cell Molecular Analysis of Influenza Vaccine Induced T Cell Responses in Adults 65 Years of Age or Older
Frontiers in Immunology 2017
Open access · CC-BY
Chronic Inflammation in Immune Aging: Role of Pattern Recognition Receptor Crosstalk with the Telomere Complex?
Aging Cell 2021
Open access · CC-BY
Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells
UConn Health 2019
Open access · US-GOV
Vaccination Efficacy With Metformin in Older Adults: A Pilot Study
Revista de investigaci�n Cl�nica 2016
Open access · CC-BY